By expenditures
| Name | Title | Type |
|---|---|---|
| Mary Okada | President | Auditee |
| Rizalito Paglingayen | Chief Financial Officer | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 359093 | 2024 | 2025-06-17 | Ernst & Young LLP | $7.86M |
| 308414 | 2023 | 2024-06-07 | Ernst & Young LLP | $12.65M |
| 17796 | 2022 | 2023-08-30 | Ernst & Young LLP | $12.00M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 308414 | 2023 | 2024-06-07 | 976818 | 2023-002 | Significant Deficiency | - | N |
| 308414 | 2023 | 2024-06-07 | 976817 | 2023-001 | Significant Deficiency | - | I |
| 308414 | 2023 | 2024-06-07 | 400376 | 2023-002 | Significant Deficiency | - | N |
| 308414 | 2023 | 2024-06-07 | 400375 | 2023-001 | Significant Deficiency | - | I |
| 17796 | 2022 | 2023-08-30 | 599167 | 2022-002 | Significant Deficiency | - | H |
| 17796 | 2022 | 2023-08-30 | 599166 | 2022-001 | Material Weakness | - | A |
| 17796 | 2022 | 2023-08-30 | 22725 | 2022-002 | Significant Deficiency | - | H |
| 17796 | 2022 | 2023-08-30 | 22724 | 2022-001 | Material Weakness | - | A |